エドガーで原本を確認する
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 17, 2026
MaxCyte, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-40674 |
|
52-2210438 |
(State or other jurisdiction of |
|
(Commission File Number) |
|
(IRS Employer |
|
9713 Key West Avenue, Suite 400 Rockville, Maryland |
|
20850 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (301) 944-1700
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading |
|
Name of each exchange |
Common Stock, $0.01 par value |
|
MXCT |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders
At the 2026 annual meeting of stockholders of MaxCyte, Inc. (the “Company”) held on June 17, 2026 (the “Annual Meeting”), the Company’s stockholders considered and approved two proposals, each of which is described in more detail in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 29, 2026. Set forth below are the results of the matters submitted for a vote of stockholders at the Annual Meeting.
Proposal 1 – Election of Class II Directors:
|
|
||||
Nominee |
For |
|
Withhold |
|
Broker Non-Votes |
Patrick Balthrop |
39,760,379 |
|
12,728,826 |
|
17,814,976 |
Cynthia Collins |
46,886,614 |
|
5,602,591 |
|
17,814,976 |
Stanley Erck |
40,908,701 |
|
11,580,504 |
|
17,814,976 |
Proposal 2 – Ratification of the Audit Committee’s selection of CohnReznick LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026:
Votes For |
|
Votes Against |
|
Abstentions |
70,227,193 |
46,732 |
30,256 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
MaxCyte, Inc. |
|
|
|
|
Date: June 17, 2026 |
By: |
/s/ Parmeet Ahuja |
|
|
Parmeet Ahuja |
|
|
Chief Financial Officer |